ABEO · Abeona Therapeutics Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-21 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards. |
Common Stock
|
1,478 |
| 2026-07-09 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
24,880 |
| 2026-07-09 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
67,971 |
| 2026-07-09 | O'Malley Brendan M. |
SVP, Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
12,050 |
| 2026-07-09 | Vasanthavada Madhav |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
12,606 |
| 2026-06-30 | Alland Leila |
Chief Medical Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.915 to $5.9334 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
11,000 |
| 2026-06-16 | Vasanthavada Madhav |
Chief Commercial Officer |
Other↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards. |
Common Stock
|
222 |
| 2026-06-15 | Silverstein Christine Berni |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.68 to $5.73 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
18,160 |
| 2026-06-09 | O'Malley Brendan M. |
SVP, Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
6,305 |
| 2026-06-09 | Vasanthavada Madhav |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
5,450 |
| 2026-06-09 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
25,646 |
| 2026-06-09 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
13,421 |
| 2026-06-09 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
31,916 |
| 2026-06-08 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
24,428 |
| 2026-06-08 | O'Malley Brendan M. |
SVP, Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
4,826 |
| 2026-06-08 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
10,271 |
| 2026-06-08 | Vasanthavada Madhav |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
4,170 |
| 2026-05-26 | Alvino Mark |
Director |
Gift↓
|
Common Stock
|
500 |
| 2026-05-22 | Alvino Mark |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.44 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
6,500 |
| 2026-05-15 | Crombez Eric |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.44 to $5.66 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
26,143 |
| 2026-05-11 | Vasanthavada Madhav |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.90 to $6.00 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
5,548 |
| 2026-04-01 | Goldan Keith A. |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-01 | Goldan Keith A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on April 1, 2027. |
Common Stock
|
32,751 |
| 2026-03-31 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.31 to $4.43 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
29,985 |
| 2026-03-16 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. |
Common Stock
|
785 |
| 2026-02-02 | Alland Leila |
Chief Medical Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
18,065 |
| 2026-02-02 | Crombez Eric |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
16,284 |
| 2026-02-02 | Alvino Mark |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
2,000 |
| 2026-02-02 | Wuchterl Donald A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
14,814 |
| 2026-02-02 | Silverstein Christine Berni |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.12 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
20,070 |
| 2026-01-26 | Alland Leila |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Silverstein Christine Berni |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Charles Faith L. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Alvino Mark |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Amoroso Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Zeiher Bernhardt G |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Crombez Eric |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-26 | Wuchterl Donald A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
All of the restricted stock will vest on January 26, 2027. |
Common Stock
|
37,313 |
| 2026-01-22 | O'Malley Brendan M. |
SVP, Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
13,578 |
| 2026-01-22 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
69,832 |
| 2026-01-22 | Vasanthavada Madhav |
Chief Commercial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.35 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
12,610 |
| 2026-01-22 | Vazzano Joseph Walter |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.38 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
18,666 |
| 2026-01-21 | Alvino Mark |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.21 to $5.235 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
13,500 |
| 2026-01-20 | Vasanthavada Madhav |
Chief Commercial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029 |
Common Stock
|
76,621 |
| 2026-01-20 | Seshadri Vishwas |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029. |
Common Stock
|
365,422 |
| 2026-01-20 | O'Malley Brendan M. |
SVP, Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029. |
Common Stock
|
113,949 |
| 2026-01-20 | Vazzano Joseph Walter |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock will vest one-third on each of January 20, 2027, January 20, 2028, and January 20, 2029. |
Common Stock
|
133,595 |
| 2025-12-29 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sale of 25,000 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.215 to $5.41 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
25,000 |
| 2025-11-13 | Alvino Mark |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.885 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
Common Stock
|
15,000 |
| 2025-10-16 | Seshadri Vishwas |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. |
Common Stock
|
249 |